This is consistent with the literature: treatment with tamoxifen or fulvestrant in patient-derived samples and xenograft models of ER+ breast tumor-selected CSC-like cells through upregulation of the Jagged1-Notch4 signaling axis [18]. Here, ESR1 is linked to breast neoplasm.